Analysis of Isocitrate Dehydrogenase -2 (IDH-2) Activity in Human Serum as a Biomarker in Chemotherapy Patients of Breast Carcinoma: A Case-Control Study
Journal Title: Journal of Clinical and Diagnostic Research - Year 2017, Vol 11, Issue 5
Abstract
Introduction: Breast cancer represents a major public health problem in women worldwide. For many cancers, serum tumour markers play an important role in patient treatment and monitoring. Isocitrate dehydrogenase enzyme is also used as a biomarker for various types of cancer. Aim: The purpose of this study was to determine serum Isocitrate dehydrogenase-2 (IDH-2) enzyme activity in breast cancer patients (pre and post chemotherapy) and also correlate the changes in enzyme activity with stages of cancer and control groups. Materials and Methods: In this case-control study, histologically confirmed 40 female patients aged 28-80 years who fulfilled the criteria for diagnosis of invasive breast cancer were selected in our study groups from surgery outpatient department of SS Hospital, BHU, Varanasi, India, and 40 healthy age matched females were selected between October 2013 to July 2015. The estimation of serum IDH-2 enzyme activity in before and after two cycles of neoadjuvant chemotherapy patients was performed by spectrophotometry assay. Results: The mean serum IDH-2 activity in cases (Mean±SD) was significantly more than control group (p<0.001). The mean serum IDH-2 activity in cases was significantly decrease after neo-adjuvant chemotherapy (p=0.019). In stage II pre chemotherapy patients serum IDH-2 activity was higher than post chemotherapy (p<0.05), but in stage III the correlation between pre and post chemotherapy patients serum IDH-2 activity was not significant (p-value>0.05). Conclusion: The serum IDH-2 can be a potential biomarker in breast carcinoma and can be used for prognosis and monitoring the chemotherapy response of the patients.
Authors and Affiliations
Roshni Gavel, S. P. Mishra, Seema Khanna, Rahul S. Khanna, Agni Gautam Shah
Keywords
Related Articles
- EP ID EP341162
- DOI 10.7860/JCDR/2017/21886.9842
- Views 65
- Downloads 0
Melanoacanthoma of Pinna-Treated with Skin Grafting: A Case Report
ABSTRACT Melanoacanthoma is a very rare cutaneous lesion and it is considered to be a benign neoplasm, which is composed of large dendritic melanocytes and epidermal keratinocytes. Very few case reports of melanoacanthom...
Treatment of Fistula-in-Ano with Tight (Cutting) Seton: Analysis of Outcomes and Efficacy Assessment
Introduction: Management of fistula-in-ano is a surgical challenge. Various methods for the treatment of anal fistulas have a range of success rates and use of the cutting seton is still questionable. Aim: The aim of thi...
An Innovative Technique to Evaluate Quantitative Pupillary Light Reflex by Dynamic Pupillometry using Infrared Videography
ABSTRACT Introduction: An innovative approach was designed to quantify the pupillary light reflex using infrared and white light illumination. This method is convenient to detect pupil edges, area and the diameter of pup...
Modulation of Lung Function by Increased Nitric Oxide Production
Introduction: Cigarette smoking reduces endogenous Nitric Oxide (NO) production by reducing Nitric Oxide Synthase (NOS) activity, which is one of the probable reason for increased rate of pulmonary diseases in smokers. N...
Role of Prostate-Specific Antigen (PSA) in Patients with Benign Prostate Hyperplasia
ABSTRACT Introduction: Prostate-Specific Antigen (PSA) is an organ specific rather than cancer specific hormone. It is a single chain glycoprotein produced by epithelial cells of the prostate gland. Role of PSA in carcin...